Vivimed Labs Limited
Vivimed Labs Ltd is primarily engaged in the business of APIs, CDMO, Finished Dosage Formulation, Specialty Chemicals and retail branded formulation manufacturing.
What Vivimed files
- Others28
- Important21
- Updates11
- Board Meeting6
- Results3
Vivimed Labs Limited has informed the Exchange about Corporate Insolvency Resolution Process
Vivimed Labs Limited has informed the Exchange about Corporate Insolvency Resolution Process
Vivimed's share transfer agent reported no re-lodgement requests for physical shares in June. Zero requests were received, processed, approved, or rejected, indicating no operational activity in physical share transfers.
Vivimed Labs has published financial results for the quarter and year ended March 31, 2026. These results were approved by the Board of Directors. Full details are available on stock exchange and company websites.
Vivimed Labs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018